Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://tediwad798348.ourcodeblog.com/39352227/retaglutide-a-promising-glp-1-receptor-agonist